MannKind Stock Price - MNKD

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 1.79 ▲ 0.03 (1.70%)
Company Name Stock Ticker Symbol Market Type
MannKind Corporation MNKD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.06 3.53% 1.76 1.81 1.69 1.72 1.70 00:00:02
Bid Price Ask Price Spread Spread % News
1.66 1.90 0.24 12.63% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,325 4,819,545 $ 1.76 $ 8,491,335 2,753,444 1.02 - 2.34
Last Trade Time Type Quantity Stock Price Currency
18:57:55 formt 100 $ 1.7899 USD

MannKind Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 363.28M 206.41M $ -86.98M -0.61 -16.30 201.72M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

MannKind News

Loading Messages....

Latest MNKD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNKD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.551.871.501.685,746,5480.2113.55%
1 Month1.341.871.251.533,591,6380.4231.34%
3 Months1.311.871.121.392,657,8810.4534.35%
6 Months1.031.871.021.312,321,3700.7370.87%
1 Year1.302.341.021.442,428,6340.4635.38%
3 Years0.68496.960.462.223,359,4191.08156.97%
5 Years5.807.880.412.544,184,187-4.04-69.66%

MannKind Description

MannKind Corp is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of therapeutic products and solutions for the patients with the diseases such as diabetes. Its products and technologies include Afrezza, Dry powder formulation, Inhalation profiling, Oral inhalers and others. The company has following products in the pipeline: Epinephrine technosphere, Treprostinil technosphere, and Palonosetron technosphere.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.